Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:12
  • preuzimanja u poslednjih 30 dana:7

Sadržaj

članak: 7 od 405  
Back povratak na rezultate
2022, vol. 61, br. 1, str. 48-53
Uticaj pandemije virusa COVID-19 na učestalost i kliničku prezentaciju dijabetesa tipa 1 kod dece i adolescenata - iskustvo jednog centra
aKlinički centar Niš, Klinika za dečje interne bolesti + Univerzitet u Nišu, Medicinski fakultet
bKlinički centar Niš, Klinika za dečje interne bolesti
cKlinički centar Niš, Klinika za plućne bolesti

e-adresastankovic_sandra@yahoo.com
Ključne reči: COVID-19; deca; DKA
Sažetak
Pandemija virusa COVID-19 drastično je promenila funkcionisanje zdravstvenog sistema. Cilj našeg istraživanja je da prikaže incidenciju i kliničku prezentaciju dece i adolescenata sa novootkrivenim tipom 1 šećerne bolesti (DM tip 1) tokom prve godine pandemije virusa COVID-19 i da dobijene podatke uporedi sa podacima iz prethodnih godina. Tokom ispitivanog perioda, dijagnostikovan je 41 bolesnik. Joint point analizom utvrđen je godišnji porast u periodu od 2007. do 2012. godine (APC 8,94%), praćen smanjenjem broja u periodu od 2012. od 2015. godine (APC 6,88%) i statistički značajnim uvećanjem od 2015. do 2020. godine (APC 14,20%). Broj novoobolele dece tokom prve godine COVID-19 pandemije bio je veći, ali bez statističke značajnosti. Procenat dece sa dijabetesnom ketoacidozom (DKA) u vreme postavljanja dijagnoze DM tip 1, u ispitivanom periodu, bio je značajno veći nego u prethodnim godinama (84,8% prema 34,6%; p < 0,001). Naši rezultati ukazuju na potencijalno dijabetogeni efekat COVID-19 virusa. Potrebne su opsežnije i dugotrajnije studije da bi se utvrdile prave dimenzije ovog uticaja. Drastičan porast DKA u vreme postavljanja dijagnoze DM tip 1, tokom pandemije COVID-19 virusa zahteva poboljšanje preventivnih mera.
Reference
*** (2020) Joinpoint Regression Program (computer program): Version 4.8.0.1. statistical methodology and applications branch, surveillance research program. National Cancer Institute
Dimeglio, L.A., Albanese-O'neill, A., Muñoz, C.E., Maahs, D.M. (2020) COVID-19 and children with diabetes-updates, unknowns, and next steps: First, do no extrapolation. Diabetes Care, 43(11), 2631-2634
Duca, L.M., Wang, B., Rewers, M., Rewers, A. (2017) Diabetic ketoacidosis at diagnosis of type 1 diabetes predicts poor long-term glycemic control. Diabetes Care, 40(9), 1249-1255
EURODIAB Substudy 2 Study Group (2002) Rapid early growth is associated with increased risk of childhood type 1 diabetes in various European populations. Diabetes Care, 25(10), 1755-1760
European Centre for Disease Prevention and Control (2021) Data on 14-day notification rate of new COVID-19 cases and deaths. 2021 april 22nd 'cited 2021 april 22nd ', https://www.ecdc.europa.eu/en/publicationsdata/data-national-14-day-notification-rate-covid-19
Fu, J., Zhou, B., Zhang, L., Balaji, K.S., Wei, C., Liu, X., et al. (2020) Expressions and significances of the angiotensinconverting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19. Mol Biol Rep, 14, 1-10
Ho, J., Rosolowsky, E., Pacaud, D., Huang, C., Lemay, J.A., Brockman, N., et al. (2021) Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the COVID-19 pandemic. Pediatr Diabetes, 1-6
International Diabetes Federation (2017) IDF diabetes atlas. Brussels: International Diabetes Federation, 8th edition
Ješić, M.D., Ješić, M.M., Stanisavljević, D., Zdravković, V., Bojić, V., Vranješ, M. (2013) Ketoacidosis at presentation of type 1 diabetes mellitus in children: A retrospective 20-year experience from a tertiary care hospital in Serbia. Eur J Pediatr, 172(12), 1581-1585
Li, M.Y., Li, L.Y., Zhang, Y., Wang, X.S. (2020) Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infectious Diseases of Poverty, 9(1), 45
Sipetić, S., Maksimović, J., Vlajinac, H., Ratkov, I., Sajić, S., Zdravković, D. (2005) Rising incidence of type 1 diabetes in Belgrade children aged 0-14 years in the period from 1982 to. J Endocrinol Investig, 36, 307-312
Stanković, S., Vuković, R., Vorgucin, I., Zdravković, V., Folić, N., Živić, S. (2021) First report on the nationwide prevalence of paediatric type 1 diabetes in Serbia and temporal trends of diabetes ketoacidosis at diagnosis-a multicentre study. Journal of Pediatric Endocrinology and Metabolism, 34(2), 225-229
The Diamond Project Group (2006) Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med, 23, 857-866
Tittel, S.R., Rosenbauer, J., Kamrath, C., Ziegler, J., Reschke, F., Hammersen, J., Mönkemöller, K., Pappa, A., Kapellen, T., Holl, R.W. (2020) Did the COVID-19 lockdown affect the incidence of pediatric type 1 diabetes in Germany?. Diabetes Care, 43(11), e172-e173
Unsworth, R., Wallace, S., Oliver, N.S., Yeung, S., Kshirsagar, A., Naidu, H., Kwong, R.M.W., Kumar, P., Logan, K.M. (2020) New-onset type 1 diabetes in children during COVID-19: Multicenter regional findings in the U.K. Diabetes Care, 43(11), e170-e171
Vuković, R., Ješić, M.D., Vorgucin, I., Stanković, S., Folić, N., Milenković, T. (2018) First report on the nationwide incidence of type 1 diabetes and ketoacidosis at onset in children in Serbia: A multicenter study. European Journal of Pediatrics, 177(8), 1155-1162
Wolfsdorf, J.I., Glaser, N., Agus, M., Fritsch, M., Hanas, R., Rewers, A., Sperling, M.A., Codner, E. (2018) ISPAD clinical practice consensus guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatric Diabetes, 19, 155-177
Yang, L., Han, Y., Nilsson-Payant, B.E., Gupta, V., Wang, P., Duan, X., et al. (2020) A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell, 27, 125-36.e7
You, W.P., Henneberg, M. (2016) Type 1 diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth. BMJ Open Diabetes Research & Care, 4(1), e000161
 

O članku

jezik rada: engleski
vrsta rada: originalan članak
DOI: 10.5633/amm.2022.0107
objavljen u SCIndeksu: 15.04.2022.
metod recenzije: dvostruko anoniman
Creative Commons License 4.0